Landscapes / Targets

topoisomerase I

7 drugs act on topoisomerase I, in 9 active trials · Any stage · updated 19 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs7

DrugHow it worksCompanyStageNext dateDetails
Topoisomerase inhibitor
Hengrui · Public 600276.SS
Approved in China Oct 2028Phase 3 trial completes
Topoisomerase I inhibitor
CSPC · Public 1093.HK
Phase 3 Jan 2028Phase 3 trial completes
—
Phase 1/2 Dec 2028Phase 1/2 trial completes
—
Phase 2 Nov 2029Phase 2 trial completes
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 —

About this list

Checked
5 of 7 drugs. The other 2 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Topoisomerase I

Following is part of Solo: you see every change to Topoisomerase I the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in